Skip Navigation
Search Menu

Print This Page
Share this page: More

Pharmacy Residency Program: Oncology

General Information

Program Type: ASHP-Accredited PGY2 Oncology 
ASHP Match Number: 537860

NOTE:   One position available for the 2017-2018 residency year.

Purpose Statement: The purpose of the PGY2 Oncology Practice Residency is to provide concentrated training focused on the care of patients with cancer. Pharmacists completing this program will be highly-qualified independent practitioners able to provide and be responsible for drug therapy outcomes for individualized patients as an integral member of the multidisciplinary healthcare team. Graduates from this program can be expected to successfully sit for board certification (BCOP) when eligible, perform practice-related research, deliver effective training and education, and serve institutions as an authoritative resource on oncology pharmacotherapy issues as a pharmacy clinical specialist. 

Program Overview: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is a National Cancer Institute (NCI)-designated Cancer Center and one of the 27 cancer centers within the National Comprehensive Cancer Network. Pharmaceutical care for the oncology patients in the Weinberg Building is provided through a pharmacy division located within the facility that operates 24 hours a day. Over the course of a year the resident will become comfortable recognizing and managing cancer- and treatment-related complications, such as pain, infection, alterations in fluids/electrolytes/nutrition, hematologic toxicities and gastrointestinal toxicities. Emphasis will be placed on gaining knowledge and skills to manage and provide recommendations for antineoplastics including chemotherapy and immunotherapy. Residents will also gain clinical research skills and be involved in different aspects of clinical research. Upon completion of this residency training, the resident will have developed the clinical skills necessary to practice as an oncology clinical specialist.

Training Experience:

  • Management of a diverse group of solid and hematologic malignancies in the acute care
    and ambulatory settings.
  • Familiarity with investigational cancer treatments as well as standard of care
  • Multidisciplinary patient care rounds
  • Patient and caregiver education
  • Multidisciplinary conferences including: Oncology Grand Rounds, Oncology Journal Club, Oncology Pain Conference, and disease-specific case conferences
  • Teaching opportunities within the cancer center as well as the University of Maryland School of Pharmacy

Rotations: Ten months are devoted to orientation and core experiences; two months are available for electives. Residents will also participate in a longitudinal Oncology Anticoagulation clinic.

two medical professionals speaking with a patient in a hospital bed

Core Rotations:

  • Medical Oncology
  • Hematologic Malignancies  
  • Myeloma, Lymphoma and Bone Marrow Transplant
  • Ambulatory Oncology
  • Pain and Palliative Care
  • Pediatric Oncology
  • Oncology Practice Administration
  • Oncology Clinical Decision Support and Investigational Drug Service

Elective Rotations:

  • Immunocompromised Infectious Disease
  • Gynecology Oncology
  • Radiation Oncology
  • Others

Benefits: http://www.hopkinsmedicine.org/pharmacy/residents/benefits/
Staffing: http://www.hopkinsmedicine.org/pharmacy/residents/about/staffing.html
On-Call: http://www.hopkinsmedicine.org/pharmacy/residents/about/on-call.html
Application Information: All applications will be accepted through PHORCAS: 
http://www.hopkinsmedicine.org/pharmacy/residents/application/index.html


Program Director: Amy Bryk, Pharm.D., BCOP, BCPS
Title: Clinical Pharmacy Specialist/Clinical Pharmacy Practitioner, Blood and Marrow Transplantation
Education: Doctor of Pharmacy, University of North Carolina at Chapel Hill


Training: Pharmacy Practice Residency - Virginia Commonwealth University Health System
Oncology Specialty Residency - The Johns Hopkins Hospital 
Dr. Bryk is a clinical pharmacy practitioner with the blood and marrow transplantation service at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital.  She is also the Director of the PGY-2 Oncology Residency Program at Johns Hopkins and serves as an Assistant Clinical Professor at the University of Maryland School of Pharmacy.  Dr. Bryk’s practice areas including bone marrow transplantation, lymphoma and multiple myeloma.   Her passion and talent for teaching is reflected in her recognition as the 2015-2016 Notre Dame of Maryland University APPE Preceptor of the Year.


Dr. Bryk is has published and presented nationally and regionally on topics within her clinical expertise.  She is a member and actively involved in the Hematology Oncology Pharmacists Association and the American Society for Blood and Marrow Transplantation.    


Contact Information


Amy Bryk, Pharm.D., BCOP, BCPS
Clinical Pharmacy Specialist/Clinical Pharmacy Practitioner, Blood and Marrow Transplantation
Program Director, PGY2 Oncology Residency
The Johns Hopkins Hospital
600 North Wolfe Street/Carnegie 180
Baltimore, MD 21287
Phone: 443-287-5193
Email:  awigles1@jhmi.edu